2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Scott M. Grundy; Neil J. Stone; Alison L. Bailey; Craig Beam; Kim K. Birtcher; Roger S. Blumenthal; Lynne T. Braun; Sarah de Ferranti; Joseph Faiella-Tommasino; Daniel E. Forman; Ronald Goldberg; Paul A. Heidenreich; Mark A. Hlatky; Daniel W. Jones; Donald Lloyd-Jones; Nuria Lopez-Pajares; Chiadi E. Ndumele; Carl E. Orringer; Carmen A. Peralta; Joseph J. Saseen; Sidney C. Smith; Laurence Sperling; Salim S. Virani; Joseph Yeboah

doi:10.1161/CIR.0000000000000624

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Scott M. Grundy, Neil J. Stone, Alison L. Bailey, Craig Beam, Kim K. Birtcher, Roger S. Blumenthal, Lynne T. Braun, Sarah de Ferranti, Joseph Faiella-Tommasino, Daniel E. Forman, Ronald Goldberg, Paul A. Heidenreich, Mark A. Hlatky, Daniel W. Jones, Donald Lloyd-Jones, Nuria Lopez-Pajares, Chiadi E. Ndumele, Carl E. Orringer, Carmen A. Peralta, Joseph J. SaseenSidney C. Smith, Laurence Sperling, Salim S. Virani, Joseph Yeboah

Research output: Contribution to journal › Review article

51 Scopus citations

Original language	English (US)
Pages (from-to)	E1046-E1081
Journal	Circulation
Volume	139
Issue number	25
DOIs	https://doi.org/10.1161/CIR.0000000000000624
State	Published - Jun 18 2019

Keywords

AHA Scientific Statements
Guidelines
biomarkers, coronary artery calcium score
cardiovascular disease
cholesterol, LDL-cholesterol
diabetes mellitus
drug therapy
ezetimibe
hydroxymethylglutaryl-CoA reductase inhibitors/statins
hypercholesterolemia
lipids
patient compliance
pharmacological
primary prevention
proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors
risk assessment
risk reduction discussion
risk treatment discussion, secondary prevention

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1161/CIR.0000000000000624

Cite this

Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., Goldberg, R., Heidenreich, P. A., Hlatky, M. A., Jones, D. W., Lloyd-Jones, D., Lopez-Pajares, N., Ndumele, C. E., Orringer, C. E., Peralta, C. A., ... Yeboah, J. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 139(25), E1046-E1081. https://doi.org/10.1161/CIR.0000000000000624

Grundy, Scott M. ; Stone, Neil J. ; Bailey, Alison L. ; Beam, Craig ; Birtcher, Kim K. ; Blumenthal, Roger S. ; Braun, Lynne T. ; de Ferranti, Sarah ; Faiella-Tommasino, Joseph ; Forman, Daniel E. ; Goldberg, Ronald ; Heidenreich, Paul A. ; Hlatky, Mark A. ; Jones, Daniel W. ; Lloyd-Jones, Donald ; Lopez-Pajares, Nuria ; Ndumele, Chiadi E. ; Orringer, Carl E. ; Peralta, Carmen A. ; Saseen, Joseph J. ; Smith, Sidney C. ; Sperling, Laurence ; Virani, Salim S. ; Yeboah, Joseph. / 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol : Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. In: Circulation. 2019 ; Vol. 139, No. 25. pp. E1046-E1081.

@article{5d82613585ac47148dbca9bcf8ccda99,

title = "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines",

keywords = "AHA Scientific Statements, Guidelines, biomarkers, coronary artery calcium score, cardiovascular disease, cholesterol, LDL-cholesterol, diabetes mellitus, drug therapy, ezetimibe, hydroxymethylglutaryl-CoA reductase inhibitors/statins, hypercholesterolemia, lipids, patient compliance, pharmacological, primary prevention, proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors, risk assessment, risk reduction discussion, risk treatment discussion, secondary prevention",

author = "Grundy, {Scott M.} and Stone, {Neil J.} and Bailey, {Alison L.} and Craig Beam and Birtcher, {Kim K.} and Blumenthal, {Roger S.} and Braun, {Lynne T.} and {de Ferranti}, Sarah and Joseph Faiella-Tommasino and Forman, {Daniel E.} and Ronald Goldberg and Heidenreich, {Paul A.} and Hlatky, {Mark A.} and Jones, {Daniel W.} and Donald Lloyd-Jones and Nuria Lopez-Pajares and Ndumele, {Chiadi E.} and Orringer, {Carl E.} and Peralta, {Carmen A.} and Saseen, {Joseph J.} and Smith, {Sidney C.} and Laurence Sperling and Virani, {Salim S.} and Joseph Yeboah",

year = "2019",

month = jun,

day = "18",

doi = "10.1161/CIR.0000000000000624",

language = "English (US)",

volume = "139",

pages = "E1046--E1081",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "25",

}

Grundy, SM, Stone, NJ, Bailey, AL, Beam, C, Birtcher, KK, Blumenthal, RS, Braun, LT, de Ferranti, S, Faiella-Tommasino, J, Forman, DE, Goldberg, R, Heidenreich, PA, Hlatky, MA, Jones, DW, Lloyd-Jones, D, Lopez-Pajares, N, Ndumele, CE, Orringer, CE, Peralta, CA, Saseen, JJ, Smith, SC, Sperling, L, Virani, SS & Yeboah, J 2019, '2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines', Circulation, vol. 139, no. 25, pp. E1046-E1081. https://doi.org/10.1161/CIR.0000000000000624

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol : Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. / Grundy, Scott M.; Stone, Neil J.; Bailey, Alison L.; Beam, Craig; Birtcher, Kim K.; Blumenthal, Roger S.; Braun, Lynne T.; de Ferranti, Sarah; Faiella-Tommasino, Joseph; Forman, Daniel E.; Goldberg, Ronald; Heidenreich, Paul A.; Hlatky, Mark A.; Jones, Daniel W.; Lloyd-Jones, Donald; Lopez-Pajares, Nuria; Ndumele, Chiadi E.; Orringer, Carl E.; Peralta, Carmen A.; Saseen, Joseph J.; Smith, Sidney C.; Sperling, Laurence; Virani, Salim S.; Yeboah, Joseph.

In: Circulation, Vol. 139, No. 25, 18.06.2019, p. E1046-E1081.

Research output: Contribution to journal › Review article

TY - JOUR

T1 - 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol

T2 - Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

AU - Grundy, Scott M.

AU - Stone, Neil J.

AU - Bailey, Alison L.

AU - Beam, Craig

AU - Birtcher, Kim K.

AU - Blumenthal, Roger S.

AU - Braun, Lynne T.

AU - de Ferranti, Sarah

AU - Faiella-Tommasino, Joseph

AU - Forman, Daniel E.

AU - Goldberg, Ronald

AU - Heidenreich, Paul A.

AU - Hlatky, Mark A.

AU - Jones, Daniel W.

AU - Lloyd-Jones, Donald

AU - Lopez-Pajares, Nuria

AU - Ndumele, Chiadi E.

AU - Orringer, Carl E.

AU - Peralta, Carmen A.

AU - Saseen, Joseph J.

AU - Smith, Sidney C.

AU - Sperling, Laurence

AU - Virani, Salim S.

AU - Yeboah, Joseph

PY - 2019/6/18

Y1 - 2019/6/18

KW - AHA Scientific Statements

KW - Guidelines

KW - biomarkers, coronary artery calcium score

KW - cardiovascular disease

KW - cholesterol, LDL-cholesterol

KW - diabetes mellitus

KW - drug therapy

KW - ezetimibe

KW - hydroxymethylglutaryl-CoA reductase inhibitors/statins

KW - hypercholesterolemia

KW - lipids

KW - patient compliance

KW - pharmacological

KW - primary prevention

KW - proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors

KW - risk assessment

KW - risk reduction discussion

KW - risk treatment discussion, secondary prevention

UR - http://www.scopus.com/inward/record.url?scp=85058498879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058498879&partnerID=8YFLogxK

U2 - 10.1161/CIR.0000000000000624

DO - 10.1161/CIR.0000000000000624

M3 - Review article

C2 - 30565953

AN - SCOPUS:85058498879

VL - 139

SP - E1046-E1081

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 25

ER -

Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Jun 18;139(25):E1046-E1081. https://doi.org/10.1161/CIR.0000000000000624